Across TCGA pan-cancer cohorts, RNU6-985P RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated RNU6-985P data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher RNU6-985P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-985P expression acts as an unfavorable survival marker.

HNSC, BRCA, and UCEC are the cancer types where RNU6-985P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Tertile	All	0.100	0.710	<.001	126	view →
BRCA	OS	Tertile	All	0.161	0.579	.018	30	view →
UCEC	OS	Tertile	All	0.103	0.678	.040	18	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: RNU6-985P tumor-vs-normal RNA expression · all RNU6-985P data types